Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HR18034 for postoperative analgesia in hemorrhoidectomy
NCT05376904Phase 2Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Jun 2022
- Primary completion
- Oct 2022
- Modality
- Small Molecules, Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of bupivacaine liposome in postoperative pain, sponsored by Hengrui Therapeutics. Started Jun 2022; status: completed.
02
Drugs
bupivacaine liposome
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05376904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05376904.